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The role of nitric oxide in cellular signaling in the past
three decades has become one of the most rapidly grow-
ing areas in biology. Nitric oxide is a gas and a free radi-
cal with an unshared electron that can regulate an ever-
growing list of biological processes. Nitric oxide is
formed from L-arginine byaf a m i l yo fe n z y m e sc a l l e d
nitric oxide synthases. These enzymes have a complex
requirement for a number of cofactors and regulators
including NADPH, tetrahydrobioterin, flavins, calmodu-
lin and heme. The enzymes are present in most cells and
tissues. In many instances, nitric oxide mediates its biolo-
gical effects by activating the soluble isoform of guanylyl
cyclase and increasing cyclic GMP synthesis from GTP.
Cyclic GMP, in turn, can activate cyclic GMP-dependent
protein kinase (PKG) and can cause smooth muscles and
blood vessels to relax, decrease platelet aggregation, alter
neuron function, etc. These effects can decrease blood
pressure, increase blood flow to tissues, alter memory
and behavior, decrease blood clotting, etc. The list of
effects of nitric oxide that are independent of cyclic GMP
formation is also growing at a rapid rate. For example,
nitric oxide can interact with transition metals such as
iron, thiol groups, other free radicals, oxygen, superoxide
anion, unsaturated fatty acids, and other molecules.
Some of these reactions result in the oxidation of nitric
oxide to nitrite and nitrate to terminate the effect, while
other reactions can lead to altered protein structure func-
tion and/or catalytic capacity. These effects probably reg-
ulate bacterial infections, inflammation of tissues, tumor
growth, and other disorders.T h e s ed i v e r s ee f f e c t so f
nitric oxide that are cyclic GMP dependent or indepen-
dent can alter and regulate numerous important physio-
logical events in cell regulation and function. Nitric oxide
can function as an intracellular messenger, an antacoid, a
paracrine substance, a neurotransmitter, or as a hormone
that can be carried to distant sites for effects. Thus, it is a
unique molecule with an array of signaling functions.
However, with any messenger molecule, there can be too
little or too much of the substance, resulting in patholo-
gical events. Some of the methods to regulate either
nitric oxide formation metabolism, or function have been
in clinical use for more than a century, as with the use of
organic nitrates and nitroglycerin in angina pectoris that
was initiated in the 1870s. Inhalation of low concentra-
tions of nitric oxide can be beneficial in premature
infants with pulmonary hypertension and increase survi-
val rates. Ongoing clinical trials with nitric oxide
synthase inhibitors and nitric oxide scavengers are exam-
ining the effects of these agents in septic shock, hypoten-
sion with dialysis, inflammatory disorders, cancer
therapy, etc. Recognition of additional molecular targets
in the areas of nitric oxide and cyclic GMP research will
continue to promote drug discovery and development
programs in the field. Current and future research will
undoubtedly expand the clinician’s therapeutic armamen-
tarium to manage a number of important diseases by per-
turbing nitric oxide formation and metabolism. Such
promise and expectations have obviously fueled the inter-
ests in nitric oxide research for a growing list of potential
therapeutic applications. There have been and will
continue to be many opportunities from nitric oxide and
cyclic GMP march to develop novel and important thera-
peutic agents. There are presently more than 80,000 pub-
lications in the area of nitric oxide research. The lecture
will discuss our discovery of the first biological effects of
nitric oxide and how the field has evolved since our origi-
nal reports in 1977. The possible utility of this signaling
pathway to facilitate novel drug development and the
creation of numerous projects in the Pharmaceutical and
biotechnology industrials will also be discussed.
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